Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Buy
68
NTES Quote, Financials, Valuation and Earnings
Last price:
$106.07
Seasonality move
:
14.96%
Day range:
$104.80 - $106.40
52-week range:
$75.85 - $110.15
Dividend yield:
2.43%
P/E ratio:
16.61x
P/S ratio:
4.68x
P/B ratio:
3.61x
Volume:
1.2M
Avg. volume:
1.4M
1-year change:
7.74%
Market cap:
$68.5B
Revenue:
$14.7B
EPS (TTM):
$6.40
NetEase Number of Institutional Trades
NetEase Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$11.9B
(Last 6 Months)
Current Institutional Ownership Percentage
16.17%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$18.3B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NetEase Institutional Ownership
-
What Percentage Of NTES Is Owned by Institutions?
16.17% of NTES is owned by institutions.
-
How Many Institutions Own NTES Shares?
NetEase stock is owned by 926 institutional shareholders at this time.
-
Have Institutions Been Buying NTES Stock?
Yes, institutions have bought 65.7M shares of NTES in the last quarter.
-
Have Institutions Been Selling NTES Stock?
Yes, institutions have sold 102.8M shares of NTES over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
